Metastatic renal cell cancer: Major response to oxaliplatin, 5-fluorouracil, L-folinic acid (FOL-FOX) combination

被引：0
|
作者：
Chauffert, B [1 ]
Bonnotte, B [1 ]
Chvetzoff, G [1 ]
Flesch, M [1 ]
机构：
[1] CHU Dijon, Serv Med Interne Immunol Clin & Oncol, F-21034 Dijon, France
来源：
PRESSE MEDICALE | 1998年 / 27卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
  • [41] Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer
    D Cunningham
    S Falk
    D Jackson
    British Journal of Cancer, 2002, 86 : 1677 - 1683
  • [42] Neoadjuvant treatment with cetuximab, 5-fluorouracil, folinic acid and oxaliplatin in unresectable retroperitoneal recurrent colon cancer
    Trojan, J.
    Lubomierski, N.
    Lehnert, T.
    Engels, K.
    Zeuzem, S.
    Bechstein, W. O.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2008, 46 (08): : 776 - 779
  • [43] Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracil
    Comella, P
    Palmieri, G
    Beneduce, G
    Casaretti, R
    Daponte, A
    Gravina, A
    Frasci, G
    Biondi, E
    Comella, G
    ONCOLOGY, 1996, 53 (03) : 198 - 203
  • [44] Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer
    Gianluca Masi
    Samanta Cupini
    Lorenzo Marcucci
    Elisa Cerri
    Fotios Loupakis
    Giacomo Allegrini
    Isa Maura Brunetti
    Elisabetta Pfanner
    Maurizio Viti
    Orlando Goletti
    Franco Filipponi
    Alfredo Falcone
    Annals of Surgical Oncology, 2006, 13 : 58 - 65
  • [45] Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
    Masi, G
    Cupini, S
    Marcucci, L
    Cerri, E
    Loupakis, F
    Allegrini, G
    Brunetti, IM
    Pfanner, E
    Viti, M
    Goletti, O
    Filipponi, F
    Falcone, A
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) : 58 - 65
  • [46] CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA
    Taieb, Julien
    Maughan, Tim
    Bokemeyer, Carsten
    Van Cutsem, Eric
    Brodowicz, Thomas
    Folprecht, Gunnar
    Esser, Regina
    Schlichting, Michael
    Tabernero, Josep
    ANNALS OF ONCOLOGY, 2012, 23 : 11 - 11
  • [47] A SHORT-TERM INFUSION REGIMEN OF CISPLATIN, 5-FLUOROURACIL AND L-FOLINIC ACID IN ADVANCED HEAD AND NECK-CARCINOMA
    MELI, M
    PALMERI, S
    LEONARDI, V
    DANOVA, M
    FAILLA, G
    RUSSO, A
    BRUGNATELLI, S
    FERRARA, P
    BENAZZO, M
    RAUSA, L
    ONCOLOGY REPORTS, 1994, 1 (06) : 1133 - 1138
  • [48] Bimonthly Chemotherapy with Oxaliplatin, Irinotecan, Infusional 5-Fluorouracil/Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with Irinotecan- or Oxaliplatin-Based Chemotherapy
    Nobili, S.
    Checcacci, D.
    Filippelli, F.
    Del Buono, S.
    Mazzocchi, V.
    Mazzei, T.
    Mini, E.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 622 - 631
  • [49] PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC COLORECTAL-CANCER RECEIVING 5-FLUOROURACIL AND FOLINIC ACID
    STEINBERG, J
    ERLICHMAN, C
    GADALLA, T
    FINE, S
    WONG, A
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (11) : 1817 - 1820
  • [50] Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer
    Cure, H
    Chevalier, V
    Pezet, D
    Bousquet, J
    Focan, C
    Levi, F
    Garufi, C
    Chipponi, J
    Chollet, P
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4649 - 4653
12345